It is a chemicals public limited company based in Delhi, Delhi, India, established in 2006.
2006 | Delhi, Delhi, India | Struck OffCorwis Pharmaceuticals Limited, a struck off public limited company, was established on 17 March 2006 in Delhi, Delhi, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24230DL2006PLC147642. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
Its leadership includes Dheeraj Kumar Arora (Additional Director), Gopi Nath Sahu (Director), Nidhi Sharma (Additional Director). Past directors included Manisha Manocha, Monika Sharma, Siva Kumar Appukuttan Sukesini. It holds no open charges and ₹2.00 Cr settled loans. Its latest AGM occurred on 10 May 2014, with the balance sheet filed on 31 March 2014. It is based at 201, Mohan Place, Lsc Block-C, Saraswati Vihar, Delhi, Delhi, 110034.
U24230DL2006PLC147642
147642
17 March 2006
₹0.50 M
₹0.50 M
Roc Delhi
Unlisted
Struck Off
Explore comprehensive insights into Corwis Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dheeraj Kumar Arora | Additional Director | 19 Aug 2011 | Current |
| Gopi Nath Sahu | Director | 15 Dec 2009 | Current |
| Nidhi Sharma | Additional Director | 03 Aug 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 15 Dec 2009 | Past |
| Pramod Abcsdd | Director | 19 Aug 2011 | Past |
| Pramod Abcsdd | Whole-Time Director | 31 Mar 2012 | Past |
| Pramod Abcsdd | Director | 03 Jan 2007 | Past |
| Pramod Abcsdd | Additional Director | 16 May 2008 | Past |
| Pramod Abcsdd | Additional Director | 24 Feb 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Corwis Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Corwis Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹20,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Dec 2011 | Icici Bank Limited | ₹2.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Corwis Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Corwis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Corwis Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Corwis Pharmaceuticals Limited last Annual general meeting of members was held on 10 May 2014 as per latest MCA records. was completed.
Progress on Corwis Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2014 with Roc Delhi. was documented.
A charge registered on 09 Dec 2011 via Charge ID 10325582 with Icici Bank Limited was fully satisfied on 24 Sep 2012. was recorded as a recent event.
A charge with Icici Bank Limited amounted to Rs. 20.00 M with Charge ID 10325582 was registered on 09 Dec 2011. was recorded as a recent event.
Dheeraj Kumar Arora was appointed as a Additional Director was appointed as a Additional Director on 19 Aug 2011 & has been associated with this company since 14 years 3 months . was recorded as a recent event.
Nidhi Sharma was appointed as a Additional Director was appointed as a Additional Director on 03 Aug 2010 & has been associated with this company since 15 years 3 months . was recorded as a recent event.
The CIN of Corwis Pharmaceuticals Limited is U24230DL2006PLC147642.
Corwis Pharmaceuticals Limited is headquartered at 201, Mohan Place, Lsc Block-C, Saraswati Vihar, Delhi, Delhi, 110034.
Corwis Pharmaceuticals Limited was incorporated on 17 March 2006.
The current directors of Corwis Pharmaceuticals Limited are
The primary industry of Corwis Pharmaceuticals Limited is Chemicals.
Corwis Pharmaceuticals Limited is unlisted.
The authorized capital of Corwis Pharmaceuticals Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX